FTD Stock Overview
Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Financière de Tubize SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €90.90 |
| 52 Week High | €93.90 |
| 52 Week Low | €77.80 |
| Beta | 0.47 |
| 1 Month Change | -3.09% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | 12.92% |
| 5 Year Change | 48.05% |
| Change since IPO | 553.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| FTD | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -3.1% | -2.0% |
| 1Y | n/a | -31.9% | -0.3% |
Return vs Industry: Insufficient data to determine how FTD performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how FTD performed against the German Market.
Price Volatility
| FTD volatility | |
|---|---|
| FTD Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: FTD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine FTD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1928 | n/a | Eric Nys | www.financiere-tubize.be |
Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. The company was incorporated in 1928 and is based in Brussels, Belgium.
Financière de Tubize SA Fundamentals Summary
| FTD fundamental statistics | |
|---|---|
| Market cap | €4.09b |
| Earnings (TTM) | €88.15m |
| Revenue (TTM) | n/a |
46.4x
P/E Ratio0.0x
P/S RatioIs FTD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FTD income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €2.03m |
| Gross Profit | -€2.03m |
| Other Expenses | -€90.18m |
| Earnings | €88.15m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 25, 2024
| Earnings per share (EPS) | 1.98 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 4.4% |
How did FTD perform over the long term?
See historical performance and comparison